Can a Patient with Neuropsychiatric Symptoms Have Elevated PTH with Normal Calcium?
Yes, this presentation is entirely possible and represents either normocalcemic primary hyperparathyroidism (NPHPT) or secondary hyperparathyroidism, both of which are well-documented causes of neuropsychiatric symptoms including depression and anxiety.
Understanding the Biochemical Pattern
Normal or low serum calcium with elevated PTH is the hallmark finding of secondary hyperparathyroidism, which represents a compensatory physiologic response where increased PTH production attempts to correct calcium homeostasis 1. This pattern occurs when:
- Chronic kidney disease is present (the most common cause), as declining renal function leads to phosphate retention, decreased calcitriol production, and impaired calcium absorption 1
- Vitamin D deficiency exists, reducing intestinal calcium absorption and causing compensatory PTH elevation 1, 2
- Malabsorption syndromes are present, including post-bariatric surgery states where calcium and vitamin D absorption is impaired 1, 2
Alternatively, normocalcemic primary hyperparathyroidism (NPHPT) is characterized by elevated PTH levels in the setting of persistently normal serum calcium 3. This phenotype of primary hyperparathyroidism is increasingly recognized and patients are usually symptomatic, with PTH levels often measured during evaluation for kidney stones or osteoporosis 4.
The Neuropsychiatric Connection
Depression and anxiety are well-established manifestations of hyperparathyroidism, occurring even when calcium levels remain normal:
- Depression prevalence in primary hyperparathyroidism varies from 20-36.6% to 65.7% based on scale-based assessments, with most studies identifying moderate depression affecting approximately one-third of surgery candidates 5
- Anxiety prevalence ranges from 10.4% to 38.6% in patients with primary hyperparathyroidism 5
- Utilization of antidepressant and anxiolytic medications is significantly more comprehensive in hyperparathyroidism patients, with benzodiazepines showing an odds ratio of 1.40 and SSRIs showing an odds ratio of 1.38 compared to controls 6
- No consistent correlation exists between depression/anxiety and serum calcium levels, while PTH shows only a slight positive correlation with depression 5
This means neuropsychiatric symptoms can occur independent of hypercalcemia, making the diagnosis more challenging but no less real 5, 7.
Essential Diagnostic Workup
To differentiate between secondary hyperparathyroidism and normocalcemic primary hyperparathyroidism, you must systematically exclude secondary causes:
- Measure 25-hydroxyvitamin D levels (deficiency defined as <30 ng/mL), as vitamin D deficiency is extremely prevalent and can complicate interpretation of PTH levels 1, 8
- Assess renal function with serum creatinine and eGFR, as PTH levels begin rising when GFR falls below 60 mL/min/1.73 m² 8, 2
- Check serum phosphate, which is typically low or low-normal in primary hyperparathyroidism but elevated in CKD-related secondary hyperparathyroidism (>4.6 mg/dL in CKD stages 3-4) 1, 8
- Obtain 24-hour urine calcium, as most primary hyperparathyroidism patients demonstrate hypercalciuria (>250-300 mg/day) even when serum calcium is normal, though vitamin D deficiency can suppress this 8
- Evaluate for malabsorption, including history of bariatric surgery, as post-bariatric secondary hyperparathyroidism prevalence reaches 63% at 5 years 9
Critical pitfall: PTH reference values are 20% lower when established in vitamin D-replete individuals compared to those with unknown vitamin D status 2. Always assess vitamin D before interpreting PTH levels 8, 2.
Assay-Related Considerations
Different PTH assay generations measure different PTH fragments and can yield significantly different values, requiring use of assay-specific reference ranges 9, 8. Second-generation "intact PTH" assays (the current standard) detect both biologically active PTH and inactive fragments, which can accumulate and cause overestimation of true PTH activity, particularly in chronic kidney disease 8, 2.
Additional factors that influence PTH levels include:
- Race: PTH is higher in Black individuals compared to White individuals 2
- Age: PTH increases with age due to steady decline in GFR, with higher concentrations in people over 60 years old 2
- BMI: PTH correlates positively with body mass index 2
- Biotin supplements: Can interfere with PTH assays and lead to under or overestimation depending on assay design 8, 2
Clinical Management Implications
If secondary hyperparathyroidism is confirmed (due to vitamin D deficiency, CKD, or malabsorption):
- Treat the underlying cause: vitamin D supplementation, phosphate binders in CKD, or nutritional support post-bariatric surgery 1, 2
- Monitor PTH response to treatment, as correction of the underlying deficiency should normalize PTH levels 1
If normocalcemic primary hyperparathyroidism is diagnosed (after excluding all secondary causes):
- Recognize that these patients present more often with negative preoperative localization studies and multiglandular disease, complicating surgical management 3
- Consider parathyroidectomy based on the presence of complications such as osteoporosis, kidney stones, or refractory neuropsychiatric symptoms, though current guidelines do not specifically address neuropsychiatric symptoms as surgical indications 3, 4
- Parathyroid surgery appears beneficial for depression and anxiety, improving scores, prevalence, and severity, with postoperative excess prescription rates for anxiolytic benzodiazepines decreasing from 30% to 19% within three years 5, 6
The key clinical message: Do not dismiss neuropsychiatric symptoms in a patient with elevated PTH and normal calcium. This biochemical pattern is real, well-documented, and the neuropsychiatric manifestations may improve with appropriate treatment of the underlying parathyroid disorder 5, 6, 7.